glp-1 weight loss oral With FDA approval of Wegovy pill, new era of drugs begins Lilly launches GLP-1 pill, kicking
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 36.Ong Z.Y., Liu J.J., Pang Z.P., Grill H.J
GLP-1 agonist liraglutide prevents MK-801-induced schizophrenia-like behaviors and BDNF, CREB, p-CREB, Trk-B expressions in the hippocampus and prefrontal cortex in Balb/c mice
2024;47(7) doi: 10.1002/clc.24314
About this article Cite this article Matsushita, T., Wada, Y., Saburi, M
Related studies have shown that regulating the biological abundance of the GM can modulate the onset and progression of diseases, and thus the GM is a potential new target that may offer new therapeutic options for the treatment of metabolic diseases (Tanabe et al., 2019)
